Company Description
Vertex Pharmaceuticals represents the convergence of drug discovery technologies. The biotechnology company uses an integrated, multidisciplinary...
Key Vertex Pharmaceuticals Financials
| Company Type | Public - NASDAQ (GS): VRTX Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $199.0 |
| 2007 Employees | 1,150 |
More Vertex Pharmaceuticals Financials (11 pages)
Latest Vertex Pharmaceuticals Jobs jobs by Indeed
Rankings
- S&P 400
Competition
Competitive Landscape for Pharmaceutical Manufacture and Sale
The industry is marked by rapid advances in scientific knowledge that produce ever-more effective medicines. Profitability is determined mainly by the ability to discover new drugs. The industry is...
Read more about Vertex Pharmaceuticals's competition across multiple industries
Top Vertex Pharmaceuticals Competitors
Sponsored Links
The Business Directory
Vertex Pharmaceuticals Executives
| Title | Name & Bio | Contact |
|---|---|---|
| President, CEO, and Director | Joshua S. Boger | Network | E-mail |
| EVP and CFO | Ian F. Smith | Network | E-mail |
| VP and CTO | Mark Murcko | Network | E-mail |
More Vertex Pharmaceuticals Executives
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Vertex Pharmaceuticals News
- Nobel winner Tsien a biotech bulwark [North County Times (Escondido, CA)] (08 Oct 2008 04:00:00 EDT)
- Vertex Pharmaceuticals Incorporated (VRTX) Corporate Event Announcement Notice [Wall Street Horizon] (07 Oct 2008 21:36:00 EDT)
- Telaprevir Presentations at the 59th AASLD Meeting to Feature SVR Data in Treatment-Naive and Treatment-Failure Genotype 1 HCV Patients, and Clinical... [Hepatitis Weekly] (06 Oct 2008 00:01:00 EDT)
Sponsored Opportunity
